NCT07184931

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-10-01Est. Completion: 2029-05-14

Enrollment target: 980 participants

Locations

Onyx Clinical Research - Site Number:8400021, Peoria, Arizona, United States
One of a Kind Clinical Research Center AZ, LLC-Site Number: 8400061, Scottsdale, Arizona, United States
Scottsdale Clinical Trials-Site Number: 8400145, Scottsdale, Arizona, United States
Del Sol Research Management, LLC-Site Number: 8400012, Tucson, Arizona, United States
Preferred Research Partners-Site Number: 8400018, Little Rock, Arkansas, United States
Alliance Research Institute-Site Number: 8400008, Canoga Park, California, United States
Southern California GI & Liver Centers-Site Number: 8400062, Coronado, California, United States
Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido, California, United States
GMC Clinical Research, LLC-Site Number: 8400113, Folsom, California, United States
Om Research, LLC - Lancaster-Site Number: 8400148, Lancaster, California, United States
TLC Clinical Research Inc.-Site Number: 8400030, Los Angeles, California, United States
GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019, Los Angeles, California, United States
United Medical Doctors CA-Site Number: 8400044, Murrieta, California, United States

Inflammatory Bowel Diseases (IBD)Crohn DiseaseColitis, Ulcerative

Difficult-to-treat inflammatory bowel disease (DTT-IBD) represents a heterogeneous group of patients with treatment-refr…

Multiple LocationsEst. completion Oct 31, 2032

Inflammatory Bowel Disease

This study evaluates oral Lactobacillus reuteri as an adjunct therapy for 2 months. Endoscopic assessments will be perfo…

Suqian, ChinaCompleted Mar 30, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.